Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women
Shaowei Wu1, Wen-Qing Li, Jiali Han
1Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Insights
High cholesterol (hypercholesterolemia) is linked to a higher risk of developing psoriasis and psoriatic arthritis (PsA). This association holds true even without cholesterol-lowering medication use.
Area of Science:
- Dermatology
- Cardiology
- Epidemiology
Background:
- Psoriasis is a systemic inflammatory disease linked to cardiovascular disease.
- Hypercholesterolemia is a significant cardiovascular risk factor.
- Previous studies suggest elevated cholesterol in psoriasis patients, but the causal link is unclear.
Purpose of the Study:
- To investigate the association between hypercholesterolemia and the risk of incident psoriasis.
- To determine if hypercholesterolemia increases the risk of developing psoriasis with psoriatic arthritis (PsA).
Main Methods:
- A cohort of 95,540 women from the Nurses' Health Study II (1991-2005) was analyzed.
- Physician-diagnosed hypercholesterolemia and medication use were recorded.
- Incident psoriasis and psoriasis with PsA were confirmed via questionnaires, with hazard ratios calculated.
Main Results:
- Hypercholesterolemia was associated with increased risks of incident psoriasis (HR 1.25) and psoriasis with PsA (HR 1.58).
- Long-term hypercholesterolemia (≥7 years) showed higher risks for psoriasis (HR 1.29) and psoriasis with PsA (HR 1.68).
- These associations remained significant even in individuals not using cholesterol-lowering medications.
Conclusions:
- Hypercholesterolemia is an independent risk factor for developing psoriasis.
- The findings suggest a link between hypercholesterolemia and an elevated risk of psoriatic arthritis.
- This highlights the importance of managing cholesterol for both cardiovascular and dermatological health.
Objective:
Psoriasis is a systemic inflammatory disorder associated with an increased risk of cardiovascular disease. Hypercholesterolemia is a major risk factor for cardiovascular disease, and patients with psoriasis or psoriatic arthritis (PsA) have been shown to have elevated cholesterol levels. However, it is not known whether hypercholesterolemia is associated with an increased risk of psoriasis or psoriasis with PsA. We undertook this study to determine whether a history of hypercholesterolemia is associated with the risk of developing incident psoriasis and psoriasis with PsA in a cohort of US women.
Methods:
We included a total of 95,540 participants from the Nurses' Health Study II (1991-2005). Information on personal history of physician-diagnosed hypercholesterolemia and related medication use was collected during the followup period. Clinician-diagnosed psoriasis and psoriasis with PsA were ascertained and confirmed using supplementary questionnaires. Hazard ratios (HRs) were calculated with 95% confidence intervals (95% CIs).
Results:
During 1,320,765 person-years of followup, we documented 646 participants with incident psoriasis, 165 of whom had concomitant PsA. Hypercholesterolemia was associated with elevated risks of incident psoriasis (HR 1.25 [95% CI 1.04-1.50]) and psoriasis with PsA (HR 1.58 [95% CI 1.13-2.23]) in multivariate-adjusted models. Participants with hypercholesterolemia lasting for ≥7 years were at a higher risk of developing psoriasis (HR 1.29 [95% CI 1.03-1.61]) (P for trend = 0.0002) and psoriasis with PsA (HR 1.68 [95% CI 1.12-2.52]) (P for trend = 0.002). These associations persisted among participants who never took cholesterol-lowering medications. There was no association between cholesterol-lowering drugs and risk of psoriasis or psoriasis with PsA.
Conclusion:
Our study provides evidence that hypercholesterolemia, a well-known cardiovascular risk factor, is also associated with an elevated risk of psoriasis and psoriasis with PsA.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholecystitis
